Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.
The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.
Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.
With the recent enactment of the CHIPS and Science Act, the conversation about industrial policy has started up again. Are state-directed economic policies back, and will such initiatives work?
Though the OPEC+ group has agreed to accelerate planned oil production increases, the move will likely do little to reduce prices at the pump, despite a major U.S. concession, writes author Mark Finley — and Russia appears to support the plan. Read more on the Baker Institute Blog.
This article originally appeared in the Forbes blog on June 6, 2022.
"Creating a global norm for PPA transparency is a zero-cost step to help provide energy for everyone and deliver on the low carbon future we all need," write the authors. Read their post about power purchase agreements on the Baker Institute Blog.
This article originally appeared in the Forbes blog on June 1, 2022.